Vanguard Fiduciary Trust
FBLG icon

Vanguard Fiduciary Trust’s FibroBiologics FBLG Stock Holding History

Vanguard Fiduciary Trust’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.05K Hold
6,380
– – ﹤0.01% 4055
2026
Q1 		$8.42K Buy
+6,380
New +$37.9K ﹤0.01% 4012

Other funds holding FBLG

CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust's FBLG Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its FibroBiologics (FBLG) position steady in Q2 2026 at 6,380 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #4055.

Vanguard Fiduciary Trust first reported a position in FBLG in Q1 2026 and has held it in 2 quarters since. The position peaked at $8.42K in Q1 2026. 16 funds tracked by Wall St. Rank hold FBLG as of Q2 2026.

  • Vanguard Fiduciary Trust held 6,380 shares of FibroBiologics worth $6.05K as of Q2 2026.
  • Vanguard Fiduciary Trust left its FibroBiologics share count unchanged in Q2 2026.
  • FibroBiologics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #4055 holding.
  • Vanguard Fiduciary Trust first reported a position in FibroBiologics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's FibroBiologics position peaked at $8.42K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held FibroBiologics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.